Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital Linkou Branch and School of Medicine, Chang Gung University, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333, Taiwan, ROC.
Division of Nephrology, Department of Pediatrics, Chang Gung Memorial Hospital Linkou Branch, Taiwan, ROC.
Pediatr Neonatol. 2018 Oct;59(5):474-480. doi: 10.1016/j.pedneo.2017.11.015. Epub 2017 Dec 21.
Renal replacement therapy (RRT) is becoming increasingly necessary for supporting critically ill neonates. Few studies have reported the use of RRT in the neonatal intensive care unit (NICU). Therefore, we performed a retrospective study to describe the use of RRT in our NICU and its associated efficacy, complications, and outcomes.
We identified patients requiring RRT between January 2009 and January 2017. Demographic data, mode of RRT, and associated factors were recorded. Efficacy was calculated as the percentage reduction in the blood urea nitrogen (BUN) or toxic metabolite level after 24 h of RRT. Complications including hypotension, electrolyte disturbance, and technical and catheter-related complications were documented. Measures of clinical outcome included in-hospital survival, presence of neurological sequelae, and chronic kidney disease. The chi-square test and Mann-Whitney U test were used for categorical and continuous variables, respectively.
We included 17 neonates in our study. The median gestational age at birth was 37 weeks (32-39 weeks), and the median birth weight was 2.7 kg (1.5-3.6 kg). Twelve neonates, including three with inborn errors of metabolism (IEM), received continuous RRT (CRRT), and five neonates underwent peritoneal dialysis (PD). The percentage reduction in ammonia in neonates with IEM who received CRRT was 87.2% at 24 h. The percentage reductions in BUN in the non-IEM neonates in the CRRT and PD groups were 33.7% and 23.7% at 24 h, respectively. The main complication was electrolyte disturbance including hypokalemia, hypocalcemia, and hypophosphatemia. All neonates with IEM survived, whereas the mortality rates for the non-IEM neonates in the CRRT and PD groups were 78% and 80%, respectively.
Our study findings reveal RRT to be feasible, even in preterm neonates with low birth weight. CRRT had a higher efficacy level, particularly in neonates with IEM, and the complications encountered were transient and correctable.
肾脏替代疗法(RRT)对于支持危重新生儿变得越来越必要。很少有研究报告在新生儿重症监护病房(NICU)中使用 RRT。因此,我们进行了一项回顾性研究,描述了我们 NICU 中 RRT 的使用情况及其相关的疗效、并发症和结局。
我们确定了 2009 年 1 月至 2017 年 1 月期间需要 RRT 的患者。记录了人口统计学数据、RRT 模式和相关因素。疗效计算为 RRT 后 24 小时血液尿素氮(BUN)或毒性代谢物水平降低的百分比。记录了低血压、电解质紊乱以及技术和导管相关并发症等并发症。临床结局的评估指标包括住院期间存活率、有无神经后遗症和慢性肾脏病。使用卡方检验和曼-惠特尼 U 检验分别对分类变量和连续变量进行分析。
我们的研究纳入了 17 名新生儿。出生时的中位胎龄为 37 周(32-39 周),中位出生体重为 2.7kg(1.5-3.6kg)。12 名新生儿,包括 3 名患有先天性代谢缺陷(IEM)的新生儿,接受了连续肾脏替代治疗(CRRT),5 名新生儿接受了腹膜透析(PD)。接受 CRRT 的 IEM 新生儿在 24 小时时血液中氨的降低率为 87.2%。CRRT 和 PD 组中非 IEM 新生儿的 BUN 降低率分别为 24 小时时的 33.7%和 23.7%。主要并发症为包括低钾血症、低钙血症和低磷血症在内的电解质紊乱。所有患有 IEM 的新生儿均存活,而 CRRT 和 PD 组中非 IEM 新生儿的死亡率分别为 78%和 80%。
我们的研究结果表明,RRT 是可行的,即使是在出生体重低的早产儿中也是如此。CRRT 的疗效水平更高,特别是在患有 IEM 的新生儿中,并且遇到的并发症是暂时的且可纠正的。